Durable response to nivolumab in combination with regional hyperthermia in a patient with PD-L1-negative metastatic head and neck squamous cell carcinoma.

Saved in:
Bibliographic Details
Title: Durable response to nivolumab in combination with regional hyperthermia in a patient with PD-L1-negative metastatic head and neck squamous cell carcinoma.
Authors: Berclaz LM; Department of Internal Medicine III, University Hospital, LMU Munich, Munich, Germany. luc.berclaz@med.uni-muenchen.de.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany. luc.berclaz@med.uni-muenchen.de., Burkhard-Meier A; Department of Internal Medicine III, University Hospital, LMU Munich, Munich, Germany., Lechner A; Deparment of Otorhinolaryngology, University Hospital, LMU Munich, Munich, Germany., Völkl M; Department of Internal Medicine III, University Hospital, LMU Munich, Munich, Germany., Güler SE; Department of Internal Medicine III, University Hospital, LMU Munich, Munich, Germany., Abdel-Rahman S; Department of Internal Medicine III, University Hospital, LMU Munich, Munich, Germany., Mansoorian S; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany., Kunz WG; Department of Radiology, University Hospital, LMU Munich, Munich, Germany., Knösel T; Institute of Pathology, LMU Munich, Munich, Germany., Canis M; Deparment of Otorhinolaryngology, University Hospital, LMU Munich, Munich, Germany., von Bergwelt-Baildon M; Department of Internal Medicine III, University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany., Issels RD; Department of Internal Medicine III, University Hospital, LMU Munich, Munich, Germany., Di Gioia D; Department of Internal Medicine III, University Hospital, LMU Munich, Munich, Germany., Lindner LH; Department of Internal Medicine III, University Hospital, LMU Munich, Munich, Germany.
Source: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2025 Apr 17; Vol. 74 (6), pp. 174. Date of Electronic Publication: 2025 Apr 17.
Publication Type: Case Reports; Journal Article
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1432-0851
DOI:10.1007/s00262-025-04029-9